Key Laboratory of Flexible Electronics (KLOFE) Institute of Advanced Materials (IAM), Nanjing Tech University (Nanjing Tech), 30 South Puzhu Road, Nanjing 211800, China.
State Key Laboratory of Modern Optical Instrumentations, Centre for Optical and Electromagnetic Research, College of Optical Science and Engineering, International Research Center for Advanced Photonics, Zhejiang University, Hangzhou 310058, China.
ACS Appl Mater Interfaces. 2022 Feb 23;14(7):8705-8717. doi: 10.1021/acsami.1c20722. Epub 2022 Feb 11.
Theranostic agents with fluorescence in the second near-infrared (NIR-II) window, especially in its long-wavelength region, and NIR-II-excitable photothermal effect is promising but challenging in tumor diagnosis and therapy. Here, we report a simple but effective strategy to develop semiconducting polymer nanoparticles-based theranostic agents (PBQ NPs) and demonstrate their applications for long-wavelength NIR-II fluorescence imaging beyond 1400 nm and photothermal therapy (PTT) of tumors upon excitation at 1064 nm. Both experimental results and theory calculations show that the brightness and photothermal performance of PBQ NPs can be simultaneously improved by simply increasing the repeating unit number of semiconducting polymers. For example, PBQ45 NPs have 5-fold higher brightness than PBQ5 NPs and 6.7-fold higher photothermal effect (based on PCE × ε) than PBQ3 NPs, and exhibit promising applications in long-wavelength NIR-II fluorescence abdomen imaging, image-guided tumor resection, and image-guided PTT. This study demonstrates the effectiveness and importance of repeating unit numbers in regulating the theranostic performance, which has not received enough attention before.
具有第二近红外(NIR-II)窗口荧光,特别是长波长区域荧光的治疗诊断一体化试剂,以及可被 NIR-II 激发的光热效应,在肿瘤诊断和治疗中具有广阔的应用前景,但也极具挑战性。在此,我们报告了一种简单而有效的策略,用于开发基于半导体聚合物纳米粒子的治疗诊断一体化试剂(PBQ NPs),并展示了它们在 1064nm 激发下用于长波长 NIR-II 荧光成像和肿瘤光热治疗(PTT)的应用。实验结果和理论计算均表明,通过简单地增加半导体聚合物的重复单元数量,可同时提高 PBQ NPs 的亮度和光热性能。例如,PBQ45 NPs 的亮度比 PBQ5 NPs 高 5 倍,光热效率(基于 PCE×ε)比 PBQ3 NPs 高 6.7 倍,在长波长 NIR-II 荧光腹部成像、图像引导肿瘤切除和图像引导 PTT 方面具有广阔的应用前景。本研究表明,重复单元数量在调节治疗诊断一体化试剂性能方面的有效性和重要性,这在以前的研究中尚未得到足够的重视。